Genome Engineering Evolves Brain Tumor Modeling.

Neurologia Medico-chirurgica
Tomoyuki KogaFrank B. Furnari

Abstract

Genome engineering using programmable nucleases such as transcription activator-like effector nuclease (TALEN), and clustered regularly interspaced short palindromic repeat-associated protein nine facilitated the introduction of genetic alterations at specific genomic sites in various cell types. These tools have been applied to cancer modeling to understand the pathogenic effects of the growing catalog of mutations found in human cancers. Pertaining to brain tumors, neural progenitor cells derived from human induced pluripotent stem cells (iPSCs) engineered with different combinations of genetic driver mutations observed in distinct molecular subtypes of glioblastomas, the most common form of primary brain cancer in adults, give rise to brain tumors when engrafted orthotopically in mice. These glioblastoma models recapitulate the transcriptomic signature of each molecular subtype and authentically resemble pathobiology of glioblastoma, including inter- and intra-tumor heterogeneity, chromosomal aberrations, and extrachromosomal DNA amplifications. Similar engineering with genetic mutations found in medulloblastoma and atypical teratoid rhabdoid tumors in iPSCs have led to genetically trackable models that bear clinical relevan...Continue Reading

References

Feb 1, 1977·Journal of Neurosurgery·J I AusmanJ D Fenstermacher
Jul 26, 1968·Science·P BendaW Sweet
Mar 1, 1971·Journal of Neurosurgery·H H SchmidekJ Messer
Nov 1, 1981·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·R N AuerR Anderson
Jul 2, 1998·Methods in Cell Biology·M Westphal, H Meissner
Nov 29, 2002·Cell and Tissue Research·Bert GrobbenHerman Slegers
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 19, 2010·Nature Reviews. Genetics·Fyodor D UrnovPhilip D Gregory
Dec 24, 2010·Nature Biotechnology·Jeffrey C MillerEdward J Rebar
Jan 6, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kosuke YusaNancy L Craig
Jul 9, 2011·Nature Biotechnology·Dirk HockemeyerRudolf Jaenisch
Jun 9, 2012·Neuro-oncology·Peter C HuszthyRolf Bjerkvig
Jan 5, 2013·Science·Le CongFeng Zhang
Feb 7, 2013·ELife·Martin JinekJennifer Doudna
Sep 3, 2013·Nature·Madeline A LancasterJuergen A Knoblich
Jun 14, 2014·Science·Anoop P PatelBradley E Bernstein
Sep 5, 2014·Nature Protocols·Madeline A Lancaster, Juergen A Knoblich
Feb 24, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Stanley S StylliAndrew H Kaye
Apr 30, 2015·Nature·Jarno DrostHans Clevers
May 8, 2016·Cell Stem Cell·Dirk Hockemeyer, Rudolf Jaenisch
Nov 20, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zheng WangTao Jiang
Apr 26, 2018·Cell Reports·Junko OgawaInder M Verma

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts

Related Concepts

Related Feeds

Brain Organoids in Disease Modeling

Brain organoids are three-dimensional cell culture models derived from human pluripotent stem cells. Since they resemble the embryonic brain, they can be used to help study brain biology, early brain development, and brain diseases. Discover the latest research on brain organoids in disease modeling here.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.